Ruili Su (瑞立速)瑞立速
This is a medicine registration record from NMPA data.本页为国家药监局药品注册记录。
Labeled sections from the recorded Chinese source are included below. English wording is a reference translation when one is on file, not an official English label.本记录未接入产品级适应症/安全性标注字段。
生产企业Manufacturer
- 海南灵康制药有限公司Chinese legal name: 海南灵康制药有限公司
主要成分Active Ingredients
- 石杉碱甲Shishan Jianjia
药物知识说明
石杉碱甲是一种在国家药监局注册认定的药品。该药品含有石杉碱甲-f6bfebc1等成分。
该药品关联的活性成分包括：石杉碱甲Shishan Jianjia。这些成分信息来自国家药监局数据库。
该药品标注的生产企业为：海南灵康制药有限公司Chinese legal name: 海南灵康制药有限公司。
您可以探索含有相同成分的其他药品：石杉碱甲-f6bfebc1成分药品。
本页面内容来自国家药监局数据库，MedicineGraph在此基础上提供关系图谱和知识导航。
Medicine Knowledge
This medicine (original name: 瑞立速) is a medicine registered with the national drug regulatory authority. It contains recorded ingredients as active ingredient(s).
Active ingredients associated with this product: 石杉碱甲Shishan Jianjia.
Manufacturers recorded for this product: 海南灵康制药有限公司Chinese legal name: 海南灵康制药有限公司.
Explore other medicines containing the same ingredient: 石杉碱甲 productsProducts containing this recorded ingredient.
Source: MedicineGraph authoritative database. Relationships derived from registered product information.
这是什么What is this
- 通用名/品名Recorded product name: 瑞立速Recorded Chinese name: 瑞立速
- 剂型Dosage form: 注射剂Injection
- 规格Specification: 0.4mg。0.4 mg
本段仅展示注册/说明书已记录的身份属性，不含适应症或用法建议。Identity attributes from registration/leaflet records only; no indications or usage advice.
主要成分Ingredients
生产企业Manufacturer
- 海南灵康制药有限公司Chinese legal name: 海南灵康制药有限公司
注册信息NMPA approval number
- 批准文号NMPA approval number: 国药准字H20052577
信息来源Source and scope
国家药品监督管理局（中国）药品注册数据及已接入说明书字段。National Medical Products Administration (China) medicine-registration data and linked leaflet fields.
- 品名来源Name source: 10多万条药品说明书数据库 (HIGH)Package-insert database (more than 100,000 records) (HIGH)
- 生产企业来源Manufacturer source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
- 剂型来源Dosage-form source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
范围：当前 MedicineGraph 注册记录及已记录的精确关系；非完整目录，亦不构成疗效等同主张，也不支持换用判断。不含适应症/安全性推断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence. No inferred indications/safety.
本段为已核准说明书原文摘录（非改写、非AI摘要），非正式英文标签，亦不构成用药建议。 Not an official English label and not medical advice. English wording, when shown, is a reference translation of the Chinese source label.
English translation for reference. Translated from the Chinese source label. Not an official English label and not medical advice.
NMPA approval number
国药准字H20052577
Manufacturer
Chinese legal name: 海南灵康制药有限公司 (domestically manufactured)
Indications
English translation unavailable. The original Chinese source label remains available below.
Dosage and administration
English translation unavailable. The original Chinese source label remains available below.
Adverse reactions
English translation unavailable. The original Chinese source label remains available below.
Contraindications
English translation unavailable. The original Chinese source label remains available below.
Precautions
English translation unavailable. The original Chinese source label remains available below.
Storage
English translation unavailable. The original Chinese source label remains available below.
Specification
English translation unavailable. The original Chinese source label remains available below.
中文说明书原文Original Chinese source label
批准文号
国药准字H20052577
生产企业
海南灵康制药有限公司(国产)
适应症
本品适用于良性记忆障碍，提高患者指向记忆、联想学习、图像回忆、无意义图形再认及人像回忆等能力。对痴呆患者和脑器质性病变引起的记忆障碍亦有改善作用。另外本品亦用于重症肌无力的治疗。
用法用量
取本品，每瓶用2ml灭菌注射用水溶解后肌肉注射。治疗良性记忆障碍:一次0.2mg，一日一次或遵医嘱;治疗重症肌无力:一次0.2-0.4mg，一日一次或遵医嘱。
不良反应
本品无明显不良反应，但剂量过大可引起头晕、恶心、胃肠道不适、乏力等。一般可自行消失，严重者可用阿托品对抗。
禁忌
对本品过敏者禁用，过敏体质者慎用。
注意事项
慎与碱性药物配伍。本品为可逆性胆碱酯酶抑制剂，其用量有个体差异。一般应从小剂量开始，按上述用法与用量使用或遵医嘱。不良反应明显时可自行减量。
贮藏
遮光、密封保存
规格
0.4mg。
信息来源Source and scope
国家药品监督管理局（中国）药品注册数据。National Medical Products Administration (China) medicine-registration data.
范围：当前 MedicineGraph 注册记录及已记录的精确关系；非完整目录，亦不构成疗效等同主张，也不支持换用判断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence.